Staphylococcus aureus bronchitis

*Staphylococcus aureus* bronchitis is a bacterial lower respiratory tract infection characterized by acute or chronic inflammation of the tracheobronchial tree caused by the Gram-positive bacterium *Staphylococcus aureus* Pathophysiologically, virulence factors produced by the bacterium disrupt the bronchial epithelium, provoking hypersecretion of mucus, neutrophil infiltration, and localized tissue damage that clinically manifest as a productive cough with purulent sputum, chest congestion, whe...

*Staphylococcus aureus* bronchitis is a bacterial lower respiratory tract infection characterized by acute or chronic inflammation of the tracheobronchial tree caused by the Gram-positive bacterium *Staphylococcus aureus* Pathophysiologically, virulence factors produced by the bacterium disrupt the bronchial epithelium, provoking hypersecretion of mucus, neutrophil infiltration, and localized tissue damage that clinically manifest as a productive cough with purulent sputum, chest congestion, whe...

It primarily affects the mucosal lining of the bronchi, frequently occurring as a secondary bacterial complication following viral respiratory infections, in intubated or mechanically ventilated patients, or as an acute exacerbation in individuals with structural lung disease such as bronchiectasis or chronic obstructive pulmonary disease

It primarily affects the mucosal lining of the bronchi, frequently occurring as a secondary bacterial complication following viral respiratory infections, in intubated or mechanically ventilated patients, or as an acute exacerbation in individuals with structural lung disease such as bronchiectasis or chronic obstructive pulmonary disease

Pathophysiologically, virulence factors produced by the bacterium disrupt the bronchial epithelium, provoking hypersecretion of mucus, neutrophil infiltration, and localized tissue damage that clinically manifest as a productive cough with purulent sputum, chest congestion, wheezing, and varying degrees of respiratory distress without radiographic evidence of parenchymal consolidation

Pathophysiologically, virulence factors produced by the bacterium disrupt the bronchial epithelium, provoking hypersecretion of mucus, neutrophil infiltration, and localized tissue damage that clinically manifest as a productive cough with purulent sputum, chest congestion, wheezing, and varying degrees of respiratory distress without radiographic evidence of parenchymal consolidation